Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate CancerGernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
European Urology|November 7, 2018
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian SettingsPeter K-F Chiu, Chi-Fai Ng, Axel Semjonow, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomyMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 4, 2015
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter studyAlexander Karl, Alexander Buchner, Christiane Tympner, et al.
Plos One|September 15, 2020
To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemicNina N Harke, Jan P Radtke, Boris A Hadaschik, et al.
Prostate Cancer and Prostatic Diseases|November 4, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancerNeele Heckmann, Henning Plage, Ronald Simon, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate CancerGernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
European Urology|November 7, 2018
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian SettingsPeter K-F Chiu, Chi-Fai Ng, Axel Semjonow, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomyMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 4, 2015
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter studyAlexander Karl, Alexander Buchner, Christiane Tympner, et al.
Plos One|September 15, 2020
To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemicNina N Harke, Jan P Radtke, Boris A Hadaschik, et al.
Prostate Cancer and Prostatic Diseases|November 4, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancerNeele Heckmann, Henning Plage, Ronald Simon, et al.
Pageof 22